Zimmer Biomet Holdings Revenue 2006-2019 | ZBH

Zimmer Biomet Holdings annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Zimmer Biomet Holdings revenue for the quarter ending June 30, 2019 was $1.989B, a 0.95% decline year-over-year.
  • Zimmer Biomet Holdings revenue for the twelve months ending June 30, 2019 was $7.872B, a 0.44% decline year-over-year.
  • Zimmer Biomet Holdings annual revenue for 2018 was $7.933B, a 1.66% increase from 2017.
  • Zimmer Biomet Holdings annual revenue for 2017 was $7.803B, a 1.76% increase from 2016.
  • Zimmer Biomet Holdings annual revenue for 2016 was $7.668B, a 27.85% increase from 2015.
Zimmer Biomet Holdings Annual Revenue
(Millions of US $)
2018 $7,933
2017 $7,803
2016 $7,668
2015 $5,998
2014 $4,673
2013 $4,623
2012 $4,472
2011 $4,452
2010 $4,220
2009 $4,095
2008 $4,121
2007 $3,898
2006 $3,495
2005 $3,286
Zimmer Biomet Holdings Quarterly Revenue
(Millions of US $)
Q2 2019 $1,989
Q1 2019 $1,976
Q4 2018 $2,071
Q3 2018 $1,837
Q2 2018 $2,008
Q1 2018 $2,018
Q4 2017 $2,068
Q3 2017 $1,813
Q2 2017 $1,950
Q1 2017 $1,972
Q4 2016 $1,998
Q3 2016 $1,833
Q2 2016 $1,934
Q1 2016 $1,904
Q4 2015 $1,934
Q3 2015 $1,762
Q2 2015 $1,168
Q1 2015 $1,134
Q4 2014 $1,223
Q3 2014 $1,106
Q2 2014 $1,183
Q1 2014 $1,162
Q4 2013 $1,241
Q3 2013 $1,074
Q2 2013 $1,170
Q1 2013 $1,139
Q4 2012 $1,181
Q3 2012 $1,026
Q2 2012 $1,125
Q1 2012 $1,141
Q4 2011 $1,167
Q3 2011 $1,032
Q2 2011 $1,137
Q1 2011 $1,116
Q4 2010 $1,135
Q3 2010 $965
Q2 2010 $1,058
Q1 2010 $1,063
Q4 2009 $1,107
Q3 2009 $976
Q2 2009 $1,020
Q1 2009 $993
Q4 2008 $1,030
Q3 2008 $952
Q2 2008 $1,080
Q1 2008 $1,059
Q4 2007 $1,074
Q3 2007 $903
Q2 2007 $971
Q1 2007 $950
Q4 2006 $934
Q3 2006 $820
Q2 2006 $882
Q1 2006 $860
Q4 2005 $848
Q3 2005 $763
Q2 2005 $847
Q1 2005 $829
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $28.216B $7.933B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.052B 28.21
Medtronic (MDT) Ireland $144.563B 20.30
Stryker (SYK) United States $81.936B 28.33
Boston Scientific (BSX) United States $59.271B 28.75
Baxter (BAX) United States $44.577B 27.03
EssilorLuxottica Societe Anonyme (ESLOY) France $31.834B 0.00
Coloplast (CLPBY) Denmark $27.065B 43.21
Lonza Group Ag (LZAGY) Switzerland $26.916B 0.00
Terumo (TRUMY) Japan $23.348B 26.85
Smith & Nephew SNATS (SNN) United Kingdom $20.643B 0.00
ResMed (RMD) United States $19.620B 37.41
Sunny Optical Technology (SNPTF) China $14.851B 0.00
Bio-Rad Laboratories (BIO) United States $10.257B 54.98
Insulet (PODD) United States $9.281B 549.93
Canopy Growth (CGC) Canada $9.211B 0.00
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.050B 21.02
Haemonetics (HAE) United States $6.871B 51.85
Perrigo (PRGO) Ireland $6.520B 12.01
GN STORE NORD (GNNDY) Denmark $6.268B 32.01
Aurora Cannabis (ACB) Canada $5.942B 58.40
GW Pharmaceuticals (GWPH) United Kingdom $4.611B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.773B 62.76
NuVasive (NUVA) United States $3.412B 27.20
ICU Medical (ICUI) United States $3.409B 22.11
Hutchison China MediTech (HCM) China $2.720B 0.00
Agios Pharmaceuticals (AGIO) United States $2.553B 0.00
Quidel (QDEL) United States $2.549B 25.31
National Vision Holdings (EYE) United States $2.221B 47.93
Cardiovascular Systems (CSII) United States $1.770B 0.00
Aphria (APHA) $1.652B 0.00
Phibro Animal Health (PAHC) United States $1.292B 19.36
AtriCure (ATRC) United States $1.054B 0.00
VAREX IMAGING (VREX) United States $1.047B 24.12
Omeros (OMER) United States $1.003B 0.00
NanoString Technologies (NSTG) United States $0.957B 0.00
PetIQ (PETQ) United States $0.902B 21.30
Lantheus Holdings (LNTH) United States $0.900B 23.65
Eagle Pharmaceuticals (EGRX) United States $0.806B 20.56
Cerus (CERS) United States $0.773B 0.00
MacroGenics (MGNX) United States $0.751B 0.00
Quanterix (QTRX) United States $0.687B 0.00
TG Therapeutics (TGTX) United States $0.641B 0.00
LeMaitre Vascular (LMAT) United States $0.629B 37.27
Surmodics (SRDX) United States $0.604B 114.72
OraSure Technologies (OSUR) United States $0.453B 20.97
United Health Products (UEEC) United States $0.433B 0.00
Meridian Bioscience (VIVO) United States $0.419B 13.09
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.399B 0.00
BioLife Solutions (BLFS) United States $0.395B 129.88
Utah Medical Products (UTMD) United States $0.346B 25.35
Zynex (ZYXI) United States $0.336B 35.65
Owens & Minor (OMI) United States $0.296B 8.87
Bovie Medical (APYX) United States $0.265B 0.00
Vapotherm (VAPO) United States $0.229B 0.00
Cytosorbents (CTSO) United States $0.156B 0.00
Rockwell Medical (RMTI) United States $0.154B 0.00
Fonar (FONR) United States $0.154B 8.11
Chimerix (CMRX) United States $0.148B 0.00
Female Health (VERU) United States $0.131B 0.00
InfuSystems Holdings (INFU) United States $0.098B 0.00
United-Guardian (UG) United States $0.090B 21.22
Chembio Diagnostics (CEMI) United States $0.089B 0.00
Surface Oncology (SURF) United States $0.059B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.053B 0.00
MRI INTERVENTNS (MRIC) United States $0.046B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.035B 0.00
Myomo (MYO) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00